170 related articles for article (PubMed ID: 16218880)
1. Systemic antiatherosclerotic treatment for the peripheral arterial occlusive disease patient.
Baumgartner I
Expert Opin Pharmacother; 2005 Oct; 6(13):2181-92. PubMed ID: 16218880
[TBL] [Abstract][Full Text] [Related]
2. Does the preventive effect of different drugs depend on location of the atherosclerotic process?
Poredos P; Jezovnik MK
Int Angiol; 2008 Aug; 27(4):274-80. PubMed ID: 18677288
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologic risk factor treatment of peripheral arterial disease is lacking and requires vascular surgeon participation.
Bianchi C; Montalvo V; Ou HW; Bishop V; Abou-Zamzam AM
Ann Vasc Surg; 2007 Mar; 21(2):163-6. PubMed ID: 17349357
[TBL] [Abstract][Full Text] [Related]
4. Statins and peripheral arterial disease: potential mechanisms and clinical benefits.
Alnaeb ME; Alobaid N; Seifalian AM; Mikhailidis DP; Hamilton G
Ann Vasc Surg; 2006 Sep; 20(5):696-705. PubMed ID: 16841271
[TBL] [Abstract][Full Text] [Related]
5. Undertreatment of dyslipidemia in peripheral arterial disease and other high-risk populations: an opportunity for cardiovascular disease reduction.
Hirsch AT; Gotto AM
Vasc Med; 2002; 7(4):323-31. PubMed ID: 12710848
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of medical treatment for peripheral arterial disease in Chinese high-risk patients.
Hasimu B; Li J; Yu J; Ma Y; Zhao M; Nakayama T; Ma W; Yang J; Zheng L; Li X; Luo Y; Xu Y; Zhang L; Zou L; Xiao W; Han Y; Hu D
Circ J; 2007 Jan; 71(1):95-9. PubMed ID: 17186985
[TBL] [Abstract][Full Text] [Related]
7. Emerging drugs in peripheral arterial disease.
Tulsyan N; Ouriel K; Kashyap VS
Expert Opin Emerg Drugs; 2006 Mar; 11(1):75-90. PubMed ID: 16503827
[TBL] [Abstract][Full Text] [Related]
8. Characteristics and treatments of patients with peripheral arterial disease referred to UK vascular clinics: results of a prospective registry.
Khan S; Flather M; Mister R; Delahunty N; Fowkes G; Bradbury A; Stansby G
Eur J Vasc Endovasc Surg; 2007 Apr; 33(4):442-50. PubMed ID: 17196851
[TBL] [Abstract][Full Text] [Related]
9. Optimal medical management of peripheral arterial disease.
Rice TW; Lumsden AB
Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
[TBL] [Abstract][Full Text] [Related]
10. Regarding "Pharmacologic risk factor management in peripheral arterial disease: a vade mecum for vascular surgeons".
Paraskevas KI
J Vasc Surg; 2008 Sep; 48(3):776-7; author reply 777. PubMed ID: 18727983
[No Abstract] [Full Text] [Related]
11. Pharmacological prevention of atherothrombotic events in patients with peripheral arterial disease.
Blinc A; Poredos P
Eur J Clin Invest; 2007 Mar; 37(3):157-64. PubMed ID: 17359482
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic therapy for peripheral arterial disease and claudication.
Hiatt WR
J Vasc Surg; 2002 Dec; 36(6):1283-91. PubMed ID: 12469066
[TBL] [Abstract][Full Text] [Related]
13. [Risk factor control in peripheral arterial disease can be improved. Registry study of secondary prophylactic drug therapy].
Alhadad A; Wiktorsson C; Lindblad B; Gottsäter A
Lakartidningen; 2010 Sep 29-Oct 5; 107(39):2322-5. PubMed ID: 20973248
[No Abstract] [Full Text] [Related]
14. Drug treatment of peripheral arterial disease in the elderly.
Aronow WS
Drugs Aging; 2006; 23(1):1-12. PubMed ID: 16492065
[TBL] [Abstract][Full Text] [Related]
15. Optimal risk factor modification and medical management of the patient with peripheral arterial disease.
Chi YW; Jaff MR
Catheter Cardiovasc Interv; 2008 Mar; 71(4):475-89. PubMed ID: 18307227
[TBL] [Abstract][Full Text] [Related]
16. [Multifactorial treatment of atherosclerosis].
Mangas Rojas A; Gómez Rodríguez F
Med Clin (Barc); 2007 Dec; 129(20):785-96. PubMed ID: 18093481
[TBL] [Abstract][Full Text] [Related]
17. Is there a role for oral anticoagulant therapy in patients with peripheral arterial disease?
Cosmi B; Palareti G
Curr Drug Targets Cardiovasc Haematol Disord; 2004 Sep; 4(3):269-73. PubMed ID: 15379620
[TBL] [Abstract][Full Text] [Related]
18. Supporting a call to action for peripheral artery disease: insights from two prospective clinical registries.
Hackam DG; Tan MK; Lin PJ; Mehta PG; Jaffer S; Kates M; Oh M; Grima EA; Langer A; Goodman SG; ;
J Vasc Surg; 2006 Oct; 44(4):776-81. PubMed ID: 16930931
[TBL] [Abstract][Full Text] [Related]
19. The use of secondary medical prevention after primary vascular reconstruction: studies on usage and effectiveness.
Høgh AL
Dan Med J; 2012 Sep; 59(9):B4514. PubMed ID: 22951205
[TBL] [Abstract][Full Text] [Related]
20. Current views on the management of atherosclerotic renovascular disease.
Ritchie J; Green D; Kalra PA
Ann Med; 2012 Jun; 44 Suppl 1():S98-110. PubMed ID: 22713155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
